Teladoc Health, Inc. (BMV:TDOC)
93.00
+2.73 (3.02%)
At close: Mar 9, 2026
Teladoc Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -200.32 | -1,001 | -220.37 | -13,660 | -428.79 | Upgrade
|
| Depreciation & Amortization | 208.82 | 249.81 | 265.76 | 221.69 | 219.62 | Upgrade
|
| Other Amortization | 167.62 | 133.04 | 82.96 | 46.1 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 71.76 | 790 | - | 13,403 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | -5.9 | Upgrade
|
| Stock-Based Compensation | 80.41 | 145.95 | 201.55 | 217.85 | 302.59 | Upgrade
|
| Provision & Write-off of Bad Debts | 0 | 3.8 | 4.69 | 2.82 | 10.6 | Upgrade
|
| Other Operating Activities | -35.01 | 8.65 | 3.79 | 5.95 | 139.86 | Upgrade
|
| Change in Accounts Receivable | 25.13 | -0.38 | -10.25 | -49.06 | -11.17 | Upgrade
|
| Change in Inventory | 0.4 | -9.75 | 24.1 | 14.8 | -19.49 | Upgrade
|
| Change in Accounts Payable | 11.45 | -10.37 | -4.18 | 1.88 | 1.19 | Upgrade
|
| Change in Unearned Revenue | -19.76 | -18.25 | -4.9 | 15.24 | 20.55 | Upgrade
|
| Change in Other Net Operating Assets | -16.14 | 2.42 | 6.89 | -31.25 | -35.06 | Upgrade
|
| Operating Cash Flow | 294.36 | 293.68 | 350.02 | 189.29 | 193.99 | Upgrade
|
| Operating Cash Flow Growth | 0.23% | -16.10% | 84.91% | -2.42% | - | Upgrade
|
| Capital Expenditures | -8.89 | -10.79 | -11.46 | -16.48 | -8.53 | Upgrade
|
| Cash Acquisitions | -81.9 | - | - | - | -78.66 | Upgrade
|
| Sale (Purchase) of Intangibles | -148.13 | -113.26 | -144.88 | -156.28 | -55.4 | Upgrade
|
| Investment in Securities | -27.14 | - | - | 2.51 | 60.9 | Upgrade
|
| Other Investing Activities | 0.06 | - | 0 | 2.51 | 8.72 | Upgrade
|
| Investing Cash Flow | -266 | -124.05 | -156.35 | -167.74 | -72.98 | Upgrade
|
| Long-Term Debt Repaid | -550.63 | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -550.63 | - | - | - | - | Upgrade
|
| Issuance of Common Stock | 3.09 | 8.31 | 11.13 | 12.39 | 42.59 | Upgrade
|
| Other Financing Activities | -4.11 | -0 | -0.28 | -5.89 | -1.64 | Upgrade
|
| Financing Cash Flow | -551.65 | 8.31 | 10.85 | 6.5 | 40.95 | Upgrade
|
| Foreign Exchange Rate Adjustments | 6.06 | -3.29 | 0.97 | -3.34 | -1.8 | Upgrade
|
| Net Cash Flow | -517.24 | 174.65 | 205.49 | 24.7 | 160.16 | Upgrade
|
| Free Cash Flow | 285.46 | 282.89 | 338.56 | 172.81 | 185.46 | Upgrade
|
| Free Cash Flow Growth | 0.91% | -16.44% | 95.91% | -6.82% | - | Upgrade
|
| Free Cash Flow Margin | 11.28% | 11.01% | 13.01% | 7.18% | 9.12% | Upgrade
|
| Free Cash Flow Per Share | 1.62 | 1.66 | 2.06 | 1.07 | 1.18 | Upgrade
|
| Cash Interest Paid | 15.01 | 17.32 | 17.42 | 17.36 | 18.84 | Upgrade
|
| Cash Income Tax Paid | 8.75 | 8.95 | 7.24 | 2.51 | 3.97 | Upgrade
|
| Levered Free Cash Flow | 226.14 | 229.78 | 303.95 | 176.62 | 241.62 | Upgrade
|
| Unlevered Free Cash Flow | 238.46 | 244.65 | 317.88 | 190.34 | 292.34 | Upgrade
|
| Change in Working Capital | 1.08 | -36.32 | 11.64 | -48.39 | -43.99 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.